Transdermal drug delivery may be defined, in its broadest sense, as the administration of?medicines to the skin?which will deliver the active ingredient into the systemic circulation at therapeutic levels.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Passive Transdermal Drug Delivery industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Microfluidics
Smart Pill Technology (SPT)
Market Segment by Product Application
Clinic
Hospital
Others
Finally, the report provides detailed profile and data information analysis of leading company.
3M
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Boehringer Ingelheim GmbH
Actavis, Inc.
GlaxoSmithKline plc
Bayer AG
Novartis AG
Echo Therapeutics, Inc.
Corium International, Inc.
Mylan N.V.
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Passive Transdermal Drug Delivery consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Passive Transdermal Drug Delivery market by identifying its various subsegments.
3.Focuses on the key global Passive Transdermal Drug Delivery manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Passive Transdermal Drug Delivery with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Passive Transdermal Drug Delivery submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Passive Transdermal Drug Delivery Professional Survey Report Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Passive Transdermal Drug Delivery Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Passive Transdermal Drug Delivery Segment by Type
2.1.1 Microfluidics
2.1.2 Smart Pill Technology (SPT)
2.2 Market Analysis by Application
2.2.1 Clinic
2.2.2 Hospital
2.2.3 Others
2.3 Global Passive Transdermal Drug Delivery Market Comparison by Regions (2017-2027)
2.3.1 Global Passive Transdermal Drug Delivery Market Size (2017-2027)
2.3.2 North America Passive Transdermal Drug Delivery Status and Prospect (2017-2027)
2.3.3 Europe Passive Transdermal Drug Delivery Status and Prospect (2017-2027)
2.3.4 Asia-pacific Passive Transdermal Drug Delivery Status and Prospect (2017-2027)
2.3.5 South America Passive Transdermal Drug Delivery Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Passive Transdermal Drug Delivery Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Passive Transdermal Drug Delivery Industry Impact
2.5.1 Passive Transdermal Drug Delivery Business Impact Assessment - Covid-19
2.5.2 Market Trends and Passive Transdermal Drug Delivery Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Passive Transdermal Drug Delivery Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Passive Transdermal Drug Delivery Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Passive Transdermal Drug Delivery Manufacturer Market Share
3.5 Top 10 Passive Transdermal Drug Delivery Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Passive Transdermal Drug Delivery Market
3.7 Key Manufacturers Passive Transdermal Drug Delivery Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Passive Transdermal Drug Delivery Industry Key Manufacturers
4.1 3M
4.1.1 Company Details
4.1.2 3M Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.1.3 3M Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 3M News
4.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
4.2.1 Company Details
4.2.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.2.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) News
4.3 Boehringer Ingelheim GmbH
4.3.1 Company Details
4.3.2 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.3.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Boehringer Ingelheim GmbH News
4.4 Actavis, Inc.
4.4.1 Company Details
4.4.2 Actavis, Inc. Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.4.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Actavis, Inc. News
4.5 GlaxoSmithKline plc
4.5.1 Company Details
4.5.2 GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.5.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 GlaxoSmithKline plc News
4.6 Bayer AG
4.6.1 Company Details
4.6.2 Bayer AG Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.6.3 Bayer AG Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Bayer AG News
4.7 Novartis AG
4.7.1 Company Details
4.7.2 Novartis AG Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.7.3 Novartis AG Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Novartis AG News
4.8 Echo Therapeutics, Inc.
4.8.1 Company Details
4.8.2 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.8.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Echo Therapeutics, Inc. News
4.9 Corium International, Inc.
4.9.1 Company Details
4.9.2 Corium International, Inc. Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.9.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Corium International, Inc. News
4.10 Mylan N.V.
4.10.1 Company Details
4.10.2 Mylan N.V. Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.10.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Mylan N.V. News
4.11 Noven Pharmaceuticals, Inc.
4.11.1 Company Details
4.11.2 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Noven Pharmaceuticals, Inc. News
4.12 Transdermal Corp.
4.12.1 Company Details
4.12.2 Transdermal Corp. Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Transdermal Corp. News
5 Global Passive Transdermal Drug Delivery Sales Categorized by Regions
5.1 Global Passive Transdermal Drug Delivery Revenue, Sales and Market Share by Regions
5.1.1 Global Passive Transdermal Drug Delivery Sales and Market Share by Regions (2017-2022)
5.1.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Regions (2017-2022)
5.2 North America Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
5.3 Europe Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
5.5 South America Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
6 North America Passive Transdermal Drug Delivery Market Size Categorized by Countries
6.1 North America Passive Transdermal Drug Delivery Sales, Revenue and Market Share by Countries
6.1.1 North America Passive Transdermal Drug Delivery Sales (Volume) by Countries (2017-2022)
6.1.2 North America Passive Transdermal Drug Delivery Revenue by Countries (2017-2022)
6.1.3 United States Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
6.1.4 Canada Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
6.1.5 Mexico Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
6.2 North America Passive Transdermal Drug Delivery Revenue (Value) by Manufacturers
6.3 North America Passive Transdermal Drug Delivery Sales and Market Share by Type (2017-2022)
6.4 North America Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
7 Europe Passive Transdermal Drug Delivery Market Size Categorized by Countries
7.1 Europe Passive Transdermal Drug Delivery Sales, Revenue and Market Share by Countries
7.1.1 Europe Passive Transdermal Drug Delivery Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Passive Transdermal Drug Delivery Revenue by Countries (2017-2022)
7.1.3 Germany Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
7.1.4 UK Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
7.1.5 France Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
7.1.6 Russia Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
7.1.7 Italy Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
7.1.8 Spain Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
7.2 Europe Passive Transdermal Drug Delivery Revenue (Value) by Manufacturers
7.3 Europe Passive Transdermal Drug Delivery Sales and Market Share by Type (2017-2022)
7.4 Europe Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
8 Asia-Pacific Passive Transdermal Drug Delivery Market Size Categorized by Countries
8.1 Asia-pacific Passive Transdermal Drug Delivery Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Passive Transdermal Drug Delivery Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Passive Transdermal Drug Delivery Revenue by Countries (2017-2022)
8.1.3 China Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
8.1.4 South Korea Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
8.1.5 Japan Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
8.1.6 Australia Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
8.1.7 India Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Passive Transdermal Drug Delivery Revenue (Value) by Manufacturers
8.3 Asia-pacific Passive Transdermal Drug Delivery Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
9 South America Passive Transdermal Drug Delivery Market Size Categorized by Countries
9.1 South America Passive Transdermal Drug Delivery Sales, Revenue and Market Share by Countries
9.1.1 South America Passive Transdermal Drug Delivery Sales (Volume) by Countries (2017-2022)
9.1.2 South America Passive Transdermal Drug Delivery Revenue by Countries (2017-2022)
9.1.3 Brazil Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
9.2 South America Passive Transdermal Drug Delivery Sales and Market Share by Type (2017-2022)
9.3 South America Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
10 Middle East and Africa Passive Transdermal Drug Delivery Market Size Categorized by Countries
10.1 Middle East and Africa Passive Transdermal Drug Delivery Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Passive Transdermal Drug Delivery Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Passive Transdermal Drug Delivery Revenue by Countries (2017-2022)
10.1.3 GCC Countries Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
10.1.4 Turkey Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
10.1.5 Egypt Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
10.1.6 South America Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Passive Transdermal Drug Delivery Sales and Market Share by Type
10.3 Middle East and Africa Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
11 Global Passive Transdermal Drug Delivery Market Segment by Type
11.1 Global Passive Transdermal Drug Delivery Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Passive Transdermal Drug Delivery Sales and Market Share by Type (2017-2022)
11.1.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Type (2017-2022)
11.2 Microfluidics Sales Growth Rate and Price
11.2.1 Global Microfluidics Sales Growth Rate (2017-2022)
11.2.2 Global Microfluidics Price (2017-2022)
11.3 Smart Pill Technology (SPT) Sales Growth Rate and Price
11.3.1 Global Smart Pill Technology (SPT) Sales Growth Rate (2017-2022)
11.3.2 Global Smart Pill Technology (SPT) Price (2017-2022)
12 Global Passive Transdermal Drug Delivery Market Segment by Application
12.1 Global Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
12.2 Clinic Sales Growth Rate (2017-2022)
12.3 Hospital Sales Growth Rate (2017-2022)
12.4 Others Sales Growth Rate (2017-2022)
13 Global Passive Transdermal Drug Delivery Market Forecast
13.1 Global Passive Transdermal Drug Delivery Revenue, Sales and Growth Rate (2022-2027)
13.2 Passive Transdermal Drug Delivery Market Forecast by Regions (2022-2027)
13.2.1 North America Passive Transdermal Drug Delivery Market Forecast (2022-2027)
13.2.2 Europe Passive Transdermal Drug Delivery Market Forecast (2022-2027)
13.2.3 Asia-Pacific Passive Transdermal Drug Delivery Market Forecast (2022-2027)
13.2.4 South America Passive Transdermal Drug Delivery Market Forecast (2022-2027)
13.2.5 Middle East & Africa Passive Transdermal Drug Delivery Market Forecast (2022-2027)
13.3 Passive Transdermal Drug Delivery Market Forecast by Type (2022-2027)
13.3.1 Global Passive Transdermal Drug Delivery Sales Forecast by Type (2022-2027)
13.3.2 Global Passive Transdermal Drug Delivery Market Share Forecast by Type (2022-2027)
13.4 Passive Transdermal Drug Delivery Market Forecast by Application (2022-2027)
13.4.1 Global Passive Transdermal Drug Delivery Sales Forecast by Application (2022-2027)
13.4.2 Global Passive Transdermal Drug Delivery Market Share Forecast by Application (2022-2027)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Passive Transdermal Drug Delivery Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Passive Transdermal Drug Delivery Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Passive Transdermal Drug Delivery
Figure Market Concentration Ratio and Market Maturity Analysis of Passive Transdermal Drug Delivery
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Passive Transdermal Drug Delivery Market Size by Type
Figure Global Market Share of Passive Transdermal Drug Delivery by Type in 2021
Figure Microfluidics Picture
Figure Smart Pill Technology (SPT) Picture
Table Global Passive Transdermal Drug Delivery Market Size (Volume) by Application
Figure Clinic Picture
Figure Hospital Picture
Figure Others Picture
Table Global Passive Transdermal Drug Delivery Comparison by Regions (M USD) 2017-2027
Figure Global Passive Transdermal Drug Delivery Market Size (Million US$) (2017-2027)
Figure North America Passive Transdermal Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Passive Transdermal Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Passive Transdermal Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Passive Transdermal Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Passive Transdermal Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Passive Transdermal Drug Delivery Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Passive Transdermal Drug Delivery Sales by Manufacturer (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales Market Share by Manufacturer in 2021
Table Global Passive Transdermal Drug Delivery Revenue by Manufacturer (2017-2022)
Figure Global Passive Transdermal Drug Delivery Revenue Market Share by Manufacturer in 2021
Table Global Passive Transdermal Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Passive Transdermal Drug Delivery Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Passive Transdermal Drug Delivery Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Passive Transdermal Drug Delivery Market
Table Key Manufacturers Passive Transdermal Drug Delivery Product Type
Table Mergers & Acquisitions Planning
Table 3M Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of 3M
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of 3M 2017-2022
Table 3M Main Business
Table 3M Recent Development
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson (Janssen Pharmaceuticals Inc.) 2017-2022
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Main Business
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
Table Boehringer Ingelheim GmbH Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Boehringer Ingelheim GmbH
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Boehringer Ingelheim GmbH 2017-2022
Table Boehringer Ingelheim GmbH Main Business
Table Boehringer Ingelheim GmbH Recent Development
Table Actavis, Inc. Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Actavis, Inc.
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Actavis, Inc. 2017-2022
Table Actavis, Inc. Main Business
Table Actavis, Inc. Recent Development
Table GlaxoSmithKline plc Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of GlaxoSmithKline plc
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of GlaxoSmithKline plc 2017-2022
Table GlaxoSmithKline plc Main Business
Table GlaxoSmithKline plc Recent Development
Table Bayer AG Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Bayer AG
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bayer AG 2017-2022
Table Bayer AG Main Business
Table Bayer AG Recent Development
Table Novartis AG Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Novartis AG
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novartis AG 2017-2022
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table Echo Therapeutics, Inc. Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Echo Therapeutics, Inc.
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Echo Therapeutics, Inc. 2017-2022
Table Echo Therapeutics, Inc. Main Business
Table Echo Therapeutics, Inc. Recent Development
Table Corium International, Inc. Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Corium International, Inc.
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Corium International, Inc. 2017-2022
Table Corium International, Inc. Main Business
Table Corium International, Inc. Recent Development
Table Mylan N.V. Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Mylan N.V.
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Mylan N.V. 2017-2022
Table Mylan N.V. Main Business
Table Mylan N.V. Recent Development
Table Noven Pharmaceuticals, Inc. Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Noven Pharmaceuticals, Inc.
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Noven Pharmaceuticals, Inc. 2017-2022
Table Noven Pharmaceuticals, Inc. Main Business
Table Noven Pharmaceuticals, Inc. Recent Development
Table Transdermal Corp. Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Transdermal Corp.
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Transdermal Corp. 2017-2022
Table Transdermal Corp. Main Business
Table Transdermal Corp. Recent Development
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of
Figure Global Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Global Passive Transdermal Drug Delivery Revenue and Growth Rate (2017-2022)
Table Global Passive Transdermal Drug Delivery Sales by Regions (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales Market Share by Regions in 2021
Table Global Passive Transdermal Drug Delivery Revenue by Regions (2017-2022)
Figure Global Passive Transdermal Drug Delivery Revenue Market Share by Regions in 2021
Figure North America Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Europe Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Asia-pacific Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure South America Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure North America Passive Transdermal Drug Delivery Revenue and Growth Rate (2017-2022)
Table North America Passive Transdermal Drug Delivery Sales (Volume) by Countries (2017-2022)
Table North America Passive Transdermal Drug Delivery Sales Market Share by Countries (2017-2022)
Figure North America Passive Transdermal Drug Delivery Sales Market Share by Countries in 2021
Table North America Passive Transdermal Drug Delivery Revenue by Countries (2017-2022)
Table North America Passive Transdermal Drug Delivery Revenue Market Share by Countries (2017-2022)
Figure North America Passive Transdermal Drug Delivery Revenue Market Share by Countries in 2021
Figure United States Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Canada Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Mexico Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Table North America Passive Transdermal Drug Delivery Revenue by Manufacturer (2021)
Figure North America Passive Transdermal Drug Delivery Revenue Market Share by Manufacturer in 2021
Table North America Passive Transdermal Drug Delivery Sales by Type (2017-2022)
Table North America Passive Transdermal Drug Delivery Sales Share by Type (2017-2022)
Table North America Passive Transdermal Drug Delivery Sales by Application (2017-2022)
Table North America Passive Transdermal Drug Delivery Sales Share by Application (2017-2022)
Figure Europe Passive Transdermal Drug Delivery Revenue and Growth Rate (2017-2022)
Table Europe Passive Transdermal Drug Delivery Sales (Volume) by Countries (2017-2022)
Table Europe Passive Transdermal Drug Delivery Sales Market Share by Countries (2017-2022)
Figure Europe Passive Transdermal Drug Delivery Sales Market Share by Countries in 2021
Table Europe Passive Transdermal Drug Delivery Revenue by Countries (2017-2022)
Table Europe Passive Transdermal Drug Delivery Revenue Market Share by Countries (2017-2022)
Figure Europe Passive Transdermal Drug Delivery Revenue Market Share by Countries in 2021
Figure Germany Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure UK Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure France Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Russia Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Italy Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Spain Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Table Europe Passive Transdermal Drug Delivery Revenue by Manufacturer (2021)
Figure Europe Passive Transdermal Drug Delivery Revenue Market Share by Manufacturer in 2021
Table Europe Passive Transdermal Drug Delivery Sales by Type (2017-2022)
Table Europe Passive Transdermal Drug Delivery Sales Share by Type (2017-2022)
Table Europe Passive Transdermal Drug Delivery Sales by Application (2017-2022)
Table Europe Passive Transdermal Drug Delivery Sales Share by Application (2017-2022)
Figure Asia-pacific Passive Transdermal Drug Delivery Revenue and Growth Rate (2017-2022)
Table Asia-pacific Passive Transdermal Drug Delivery Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Passive Transdermal Drug Delivery Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Passive Transdermal Drug Delivery Sales Market Share by Countries in 2021
Table Asia-pacific Passive Transdermal Drug Delivery Revenue by Countries (2017-2022)
Table Asia-pacific Passive Transdermal Drug Delivery Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Passive Transdermal Drug Delivery Revenue Market Share by Countries in 2021
Figure China Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure South Korea Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Japan Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Australia Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure India Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Southeast Asia Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Table Asia-pacific Passive Transdermal Drug Delivery Revenue by Manufacturer (2021)
Figure Asia-pacific Passive Transdermal Drug Delivery Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Passive Transdermal Drug Delivery Sales by Type (2017-2022)
Table Asia-pacific Passive Transdermal Drug Delivery Sales Share by Type (2017-2022)
Table Asia-pacific Passive Transdermal Drug Delivery Sales by Application (2017-2022)
Table Asia-pacific Passive Transdermal Drug Delivery Sales Share by Application (2017-2022)
Figure South America Passive Transdermal Drug Delivery Revenue and Growth Rate (2017-2022)
Table South America Passive Transdermal Drug Delivery Sales (Volume) by Countries (2017-2022)
Table South America Passive Transdermal Drug Delivery Sales Market Share by Countries (2017-2022)
Figure South America Passive Transdermal Drug Delivery Sales Market Share by Countries in 2019
Table South America Passive Transdermal Drug Delivery Revenue by Countries (2017-2022)
Table South America Passive Transdermal Drug Delivery Revenue Market Share by Countries (2017-2022)
Figure South America Passive Transdermal Drug Delivery Revenue Market Share by Countries in 2019
Figure Brazil Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Table South America Passive Transdermal Drug Delivery Sales by Type (2017-2022)
Table South America Passive Transdermal Drug Delivery Sales Share by Type (2017-2022)
Table South America Passive Transdermal Drug Delivery Revenue by Type (2017-2022)
Table South America Passive Transdermal Drug Delivery Revenue Share by Type (2017-2022)
Table South America Passive Transdermal Drug Delivery Sales by Application (2017-2022)
Table South America Passive Transdermal Drug Delivery Sales Share by Application (2017-2022)
Figure Middle East and Africa Passive Transdermal Drug Delivery Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Passive Transdermal Drug Delivery Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Passive Transdermal Drug Delivery Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Passive Transdermal Drug Delivery Sales Market Share by Countries in 2019
Table Middle East and Africa Passive Transdermal Drug Delivery Revenue by Countries (2017-2022)
Table Middle East and Africa Passive Transdermal Drug Delivery Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Passive Transdermal Drug Delivery Revenue Market Share by Countries in 2019
Figure GCC Countries Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Turkey Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Egypt Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure South Africa Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Table Middle East and Africa Passive Transdermal Drug Delivery Sales by Type (2017-2022)
Table Middle East and Africa Passive Transdermal Drug Delivery Sales Share by Type (2017-2022)
Table Middle East and Africa Passive Transdermal Drug Delivery Revenue by Type (2017-2022)
Table Middle East and Africa Passive Transdermal Drug Delivery Revenue Share by Type (2017-2022)
Table Middle East and Africa Passive Transdermal Drug Delivery Sales by Application (2017-2022)
Table Middle East and Africa Passive Transdermal Drug Delivery Sales Share by Application (2017-2022)
Table Global Passive Transdermal Drug Delivery Sales by Type (2017-2022)
Table Global Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales Market Share by Type in 2021
Table Global Passive Transdermal Drug Delivery Revenue by Type (2017-2022)
Table Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2022)
Figure Global Passive Transdermal Drug Delivery Revenue Market Share by Type in 2019
Figure Global Microfluidics Sales Growth Rate (2017-2022)
Figure Global Microfluidics Price (2017-2022)
Figure Global Smart Pill Technology (SPT) Sales Growth Rate (2017-2022)
Figure Global Smart Pill Technology (SPT) Price (2017-2022)
Table Global Passive Transdermal Drug Delivery Sales by Application (2017-2022)
Table Global Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales Market Share by Application in 2021
Figure Global Clinic Sales Growth Rate (2017-2022)
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales and Growth Rate (2022-2027)
Figure Global Passive Transdermal Drug Delivery Revenue and Growth Rate (2022-2027)
Table Global Passive Transdermal Drug Delivery Sales Forecast by Regions (2017-2022)
Table Global Passive Transdermal Drug Delivery Market Share Forecast by Regions (2017-2022)
Figure North Ame
3M
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Boehringer Ingelheim GmbH
Actavis, Inc.
GlaxoSmithKline plc
Bayer AG
Novartis AG
Echo Therapeutics, Inc.
Corium International, Inc.
Mylan N.V.
Noven Pharmaceuticals, Inc.
Transdermal Corp.